Mario Gabelli's NAGE Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 72,700 shares of Niagen Bioscience, Inc. (NAGE) worth $231,913, representing 0.00% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Mario Gabelli has maintained a strategic position in NAGE, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 54,500 shares. Largest reduction occurred in Q2 2026, reducing 92,300 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Niagen Bioscience (NAGE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Niagen Bioscience (NAGE) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -92,300 | Reduce 55.94% | 72,700 | $3.19 |
| Q1 2026 | +4,000 | Add 2.48% | 165,000 | $4.41 |
| Q4 2025 | +35,550 | Add 28.34% | 161,000 | $6.36 |
| Q3 2025 | -3,350 | Reduce 2.60% | 125,450 | $9.33 |
| Q2 2025 | -14,000 | Reduce 9.80% | 128,800 | $14.41 |
| Q1 2025 | +1,800 | Add 1.28% | 142,800 | $6.90 |
| Q4 2024 | -2,150 | Reduce 1.50% | 141,000 | $5.30 |
| Q3 2024 | -90,000 | Reduce 38.60% | 143,150 | $3.65 |
| Q2 2024 | -30,700 | Reduce 11.64% | 233,150 | $2.73 |
| Q1 2024 | +2,200 | Add 0.84% | 263,850 | $3.48 |
| Q4 2023 | +1,800 | Add 0.69% | 261,650 | $1.43 |
| Q3 2023 | +54,500 | Add 26.54% | 259,850 | $1.46 |
| Q2 2023 | +28,800 | Add 16.31% | 205,350 | $1.57 |
| Q1 2023 | +176,550 | New Buy | 176,550 | $1.53 |
Mario Gabelli's Niagen Bioscience Investment FAQs
Mario Gabelli first purchased Niagen Bioscience, Inc. (NAGE) in Q1 2023, acquiring 176,550 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Niagen Bioscience, Inc. (NAGE) for 14 quarters since Q1 2023.
Mario Gabelli's largest addition to Niagen Bioscience, Inc. (NAGE) was in Q1 2023, adding 176,550 shares worth $270,122.
According to the latest 13F filing for Q2 2026, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 72,700 shares of Niagen Bioscience, Inc. (NAGE), valued at approximately $231,913.
As of the Q2 2026 filing, Niagen Bioscience, Inc. (NAGE) represents approximately 0.00% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Niagen Bioscience, Inc. (NAGE) was 263,850 shares, as reported at the end of Q1 2024.